| Centre Hospitalier De L'Universite De Montreal Patent applications |
| Patent application number | Title | Published |
|---|
| 20110229891 | SYNGAP1 DYSFUNCTIONS AND USES THEREOF IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS FOR MENTAL RETARDATION - The invention identifies Syngap1 dysfunctions as causative of mental retardation. Described are methods of detecting mental retardation and methods of detecting non-syndromic mental retardation (NSMR) in a human subject. Particular methods comprise sequencing a human subject's genomic DNA for comparison with a control sequence from an unaffected individual. Also described are probes, kits, antibodies and isolated mutated Syngap1 proteins. | 09-22-2011 |
| 20110014638 | SOLUBLE FAS IN ACUTE CORONARY SYNDROMES DIAGNOSIS - The present technology provides methods and materials for the early clinical detection of acute coronary syndromes in a subject. The methods and materials comprise measuring the amount of soluble Fas in a sample obtained from a subject, comparing the amount of soluble sFas with a reference value and detecting the presence of acute coronary syndromes. | 01-20-2011 |
| 20100150931 | NOVEL RECEPTOR FOR CD40L AND USES THEREOF - The present invention relates to a novel CD40L receptor and its related activities. Methods, uses, reagents and kits for the modulation of CD40L activities related to its interaction with the novel receptor are disclosed. Also disclosed are therapeutic uses of reagents in treating CD40L-related disorders. | 06-17-2010 |
